WHO advises against use of Fluvoxamine and Colchicine in non-severe Covid patients

The anti-depressant drug Fluvoxamine and the gout drug Colchicine are not recommended for patients with mild or moderate Covid-19, says WHO.

Related Keywords

,Guideline Development Group ,World Health Organisation ,Development Group ,Global Health Emergency ,Coronavirus ,Covid 19 ,World Health Organisation Who ,Luvoxamine And Colchicine ,Ho Guideline Development Group ,Mild Covid 19 Symptoms ,Covid 19 Patients ,